Clinical Trials in New York

Showing 6521-6540 of 22,668 trials

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

NCT02193191

The purpose of this research study is to test the safety and efficacy of a drug called Plerixafor. Plerixafor is approved by the US FDA for use in increasing blood stem cell counts before collection in cancer patients. It is not yet approved for patients with sickle cell disease. The investigators want to find out if Plerixafor can be used to increase cell counts in patients with sickle cell disease.

Sickle Cell Disease

Memorial Sloan Kettering Cancer Center25 participantsStarted Sep 2014

New York, New York, United States • New York, New York, United States

COMPLETED< 1 mile

Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States

NCT03197688

The Opsumit Users registry (OPUS; NCT02126943) was developed to characterize the safety profile of Opsumit and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting. It is expected that the recruitment target of the OPUS registry cannot be achieved within the planned time period (5000 Opsumit new users by October 2018). The OrPHeUS study is designed to supplement the OPUS registry with retrospectively identified first-time Opsumit users in order to achieve the desired sample size.

Pulmonary Arterial Hypertension

Actelion2,200 participantsStarted Aug 2017

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +103 more locations

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States

Find Trials by Condition in New York

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

Outcome of Patients with Severe Functional TR According to Medical, Transcatheter or Surgical Treatment

Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease

Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening

A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Gastric Emptying in Neonates and Infants After Formula Feeding

A Study of Guselkumab in Participants With Active Lupus Nephritis

Using Dexmedetomidine Prior to Intubation in Neonates

Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate

Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.

PoNS Clinical Experience Program in Traumatic Brain Injury Patients (TBI)

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

Vitamin D to ENhance TraUma REcovery

Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder

Kids FACE FEARS Comparative Effectiveness Research

Antibiotic Prophylaxis Before Shock Wave Lithotripsy